Suchergebnisse - "Ataga, Kenneth I."

PubPharm (194)

1

Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab : a RAND/UCLA modified Delphi panel

enthalten in: Annals of hematology | 2024

von Kanter, J. | Ataga, K. | Bhasin, N. | +10

2

Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD) : a randomised, double-blind, placebo controlled, phase 1-2 trial

enthalten in: The Lancet. Haematology | 2024

von Gladwin, M. | Gordeuk, V. | Desai, P. | +26

3

Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post-2016 CDC Guideline

enthalten in: JAMA internal medicine | 2024

von Kang, H. | Wang, B. | Barner, J. | +4

4

Hydroxyurea at escalated dose versus fixed low-dose hydroxyurea in adults with sickle cell disease

enthalten in: European journal of haematology | 2024

von Ogu, U. | Mukhopadhyay, A. | Patel, K. | +5

5

Managing sickle cell disease and related complications in pregnancy : results of an international Delphi panel

enthalten in: Blood advances | 2024

von Sharma, D. | Kozanoğlu, I. | Ataga, K. | +9

6

Kidney failure outcomes in children and young adults with sickle cell disease in the United States Renal Data System

enthalten in: Pediatric nephrology (Berlin, Germany) | 2024

von Zahr, R. | Ataga, K. | Lebensburger, J. | +1

UpdateOf: Res Sq. 2023 May 26;:. - PMID 37292764

7

Comparative pharmacovigilance assessment of adverse events associated with the use of hydroxyurea, L-glutamine, voxelotor, and crizanlizumab in sickle cell disease

enthalten in: American journal of hematology | 2024

von Chen, M. | Hankins, J. | Zhang, M. | +1

8

Machine Learning Predicts Acute Kidney Injury in Hospitalized Patients with Sickle Cell Disease

enthalten in: American journal of nephrology | 2024

von Zahr, R. | Mohammed, A. | Naik, S. | +4

9

Comparative pharmacovigilance assessment of adverse events associated with the use of hydroxyurea, L‐glutamine, voxelotor, and crizanlizumab in sickle cell disease

enthalten in: American Journal of Hematology | 2024

von Chen, M. | Hankins, J. | Zhang, M. | +1

10

Hydroxyurea at escalated dose versus fixed low‐dose hydroxyurea in adults with sickle cell disease

enthalten in: European Journal of Haematology | 2024

von Ogu, U. | Mukhopadhyay, A. | Patel, K. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]